Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anshuman Panda

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
JCI Insight|August 24, 2018
Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinomaAnshuman Panda, Aguirre A de Cubas, Mark Stein, et al.
Oncogene|August 28, 2021
SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesisKevin Tong, Om A Kothari, Katherine S Haro, et al.
Scientific Reports|July 19, 2017
Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal CarcinomaSunniva Stordal Bjørklund, Anshuman Panda, Surendra Kumar, et al.
JCO Precision Oncology|June 29, 2018
Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid TumorsAnshuman Panda, Anil Betigeri, Kalyanasundaram Subramanian, et al.
The Journal of Clinical Investigation|May 10, 2016
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancerJanice M Mehnert, Anshuman Panda, Hua Zhong, et al.
The Journal of Clinical Investigation|August 24, 2018
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinomaChristof C Smith, Kathryn E Beckermann, Dante S Bortone, et al.
Journal of the National Cancer Institute|November 21, 2017
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric CancerAnshuman Panda, Janice M Mehnert, Kim M Hirshfield, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
JCI Insight|August 24, 2018
Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinomaAnshuman Panda, Aguirre A de Cubas, Mark Stein, et al.
Oncogene|August 28, 2021
SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesisKevin Tong, Om A Kothari, Katherine S Haro, et al.
Scientific Reports|July 19, 2017
Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal CarcinomaSunniva Stordal Bjørklund, Anshuman Panda, Surendra Kumar, et al.
JCO Precision Oncology|June 29, 2018
Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid TumorsAnshuman Panda, Anil Betigeri, Kalyanasundaram Subramanian, et al.
The Journal of Clinical Investigation|May 10, 2016
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancerJanice M Mehnert, Anshuman Panda, Hua Zhong, et al.
The Journal of Clinical Investigation|August 24, 2018
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinomaChristof C Smith, Kathryn E Beckermann, Dante S Bortone, et al.
Journal of the National Cancer Institute|November 21, 2017
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric CancerAnshuman Panda, Janice M Mehnert, Kim M Hirshfield, et al.
Pageof 4